Comment on Afshar-Oromieh et al.: PET imaging with a [Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

Author： Reske Sven   Winter Gordon   Baur Benjamin   Machulla Hans-Jürgen   Kull Thomas  

Publisher： Springer Publishing Company

ISSN： 1619-7070

Source： European Journal of Nuclear Medicine and Molecular Imaging, Vol.40, Iss.6, 2013-06, pp. : 969-970

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Reply to Reske et al.: PET imaging with a [Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions

By Afshar-Oromieh A.   Malcher A.   Eder M.   Eisenhut M.   Linhart H.   Hadaschik B.   Holland-Letz T.   Giesel F.   Kratochwil C.   Haufe S.   Haberkorn U.   Zechmann C.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 40, Iss. 6, 2013-06 ,pp. : 971-972

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

By Afshar-Oromieh Ali   Zechmann Christian   Malcher Anna   Eder Matthias   Eisenhut Michael   Linhart Heinz   Holland-Letz Tim   Hadaschik Boris   Giesel Frederik   Debus Jürgen   Haberkorn Uwe  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 11-20

Springer Publishing Company

Access to resources Recommend Favorite

Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer

By Lesche Ralf   Kettschau Georg   Gromov Alexey   Böhnke Niels   Borkowski Sandra   Mönning Ursula   Hegele-Hartung Christa   Döhr Olaf   Dinkelborg Ludger   Graham Keith  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 41, Iss. 1, 2014-01 ,pp. : 89-101

Springer Publishing Company

Access to resources Recommend Favorite

Proof of principle for the use of 11C-labelled peptides in tumour diagnosis with PET

By Henriksen G.   Schottelius M.   Poethko T.   Hauser A.   Wolf I.   Schwaiger M.   Wester Hans-Jürgen  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 12, 2004-12 ,pp. : 1653-1657

Springer Publishing Company

Access to resources Recommend Favorite

11C-acetate PET imaging in prostate cancer

By Morris Michael   Scher Howard  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Iss. 2, 2007-02 ,pp. : 181-184

Springer Publishing Company

Access to resources Recommend Favorite